Hypertension remains one of the most commonly encountered clinical conditions and one that health care providers can effectively treat. At least two intervention trials have demonstrated clinical benefits as a consequence of reduction of diastolic blood pressure greater than 90 mm Hg in individuals 60 years of age or older.1-3 Systolic blood pressure elevation remains more problematic, even though most would agree that systolic hypertension is at least an equal culprit in the production of cardiovascular complications, but unfortunately no intervention trial data are presently available to support aggressive treatment. Reduction of blood pressure in those at highest risk (systolic blood pressure, >180mm Hg) and in those with concomitant coronary artery disease, congestive heart failure, left ventricular enlargement, or retinopathy seems appropriate, whereas intermediate systolic levels between 160 and 180 mm Hg require a more individualized approach.4
See also p 673.
All of the therapeutic recommendations that are
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.